SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-398921
Filing Date
2014-11-06
Accepted
2014-11-05 18:09:22
Documents
9
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d780922d10q.htm 10-Q 555666
2 EX-31.1 d780922dex311.htm EX-31.1 6399
3 EX-32.1 d780922dex321.htm EX-32.1 3527
  Complete submission text file 0001193125-14-398921.txt   4285267

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT rgls-20140930.xml EX-101.INS 619774
5 XBRL TAXONOMY EXTENSION SCHEMA rgls-20140930.xsd EX-101.SCH 38085
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgls-20140930_cal.xml EX-101.CAL 48629
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgls-20140930_def.xml EX-101.DEF 236593
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgls-20140930_lab.xml EX-101.LAB 328555
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgls-20140930_pre.xml EX-101.PRE 273198
Mailing Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35670 | Film No.: 141198122
SIC: 2834 Pharmaceutical Preparations